Time, Der Spiegel, and Fortune are among the first batch of publications in Perplexity’s new publisher’s program. Time, Der Spiegel, and Fortune are among the first batch of publications in Perplexity ...

I rate Cognition Therapeutics a "Strong Buy" due to FDA alignment on two pivotal phase 3 trials zervimesine in mild-to-moderate Alzheimer's patients with low p-tau217; Successful results means NDA ...

The CLEAR-AD U19 Scholars Program is a two-year program for early-career Mayo Clinic scientists from groups understudied in biomedical research.